Your browser doesn't support javascript.
loading
XALIA: rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosis.
Ageno, Walter; Mantovani, Lorenzo G; Haas, Sylvia; Kreutz, Reinhold; Haupt, Verena; Schneider, Jonas; Turpie, Alexander Gg.
  • Ageno W; Department of Clinical and Experimental Medicine, University of Insubria, Via Guicciardini 9, Varese 21100, Italy.
  • Mantovani LG; Department of Clinical Medicine and Surgery, Università degli Studi di Napoli Federico II, Naples, Italy.
  • Haas S; Vascular Centre, Normannenstr. 34a, Munich 81925, Germany.
  • Kreutz R; Institute of Clinical Pharmacology and Toxicology, Charité-Universitätsmedizin, Berlin, Germany.
  • Haupt V; Bayer Vital GmbH, Leverkusen, K56, 51368, Germany.
  • Schneider J; Bayer Pharma AG, Muellerstr. 178 S101, Berlin 13353, Germany.
  • Turpie AG; Department of Medicine, Hamilton Health Sciences, General Division, 237 Barton Street East, Hamilton, Ontario L8L 2X2, Canada.
Thromb J ; 12: 16, 2014.
Article en En | MEDLINE | ID: mdl-25093014
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Idioma: En Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Idioma: En Año: 2014 Tipo del documento: Article